How your AST results support accurate antibiotic therapy in the battle against bacterial sepsis

23 Sept 2025

Sepsis remains one of the world’s most urgent healthcare challenges, responsible for over 11 million deaths each year. The rise of multidrug-resistant bacteria makes treatment decisions even more complex, underscoring the critical role of antimicrobial susceptibility testing (AST). This white paper explores how accurate, timely AST results guide life-saving antibiotic choices, improve patient survival, and reduce the financial burden of sepsis care. Readers will gain practical insights into current AST methods, laboratory best practices, and emerging innovations that empower clinicians, microbiologists, and stewardship teams to combat sepsis and slow the spread of antibiotic resistance.

Thermo Scientific™ Sensititre™ ARIS HiQ™ System for AST

Thermo Fisher Scientific

Achieve the comprehensive, accurate MIC values needed to guide more targeted patient therapy with the Thermo Scientific™ Sensititre™ ARIS HiQ™ System, a benchtop automated incubation and reading system for antimicrobial susceptibility testing and identification of bacterial pathogens; designed to accommodate up to 100 Sensititre™ microtitre plates within a single instrument.

(2)

Links

Tags